QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
NASDAQ:SRTS

Sensus Healthcare Stock Forecast, Price & News

$3.23
+0.31 (+10.62 %)
(As of 11/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.94
Now: $3.23
$3.41
50-Day Range
$2.37
MA: $2.71
$2.96
52-Week Range
$1.76
Now: $3.23
$4.99
Volume63,891 shs
Average Volume27,216 shs
Market Capitalization$53.30 million
P/E RatioN/A
Dividend YieldN/A
Beta0.17
Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.
Sensus Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SRTS
CUSIPN/A
Phone561-922-5808
Employees53

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.26 million
Book Value$1.70 per share

Profitability

Net Income$-1,700,000.00

Miscellaneous

Market Cap$53.30 million
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
$3.23
+0.31 (+10.62 %)
(As of 11/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SRTS News and Ratings via Email

Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions

How has Sensus Healthcare's stock been impacted by Coronavirus?

Sensus Healthcare's stock was trading at $3.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SRTS stock has decreased by 0.6% and is now trading at $3.23.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Sensus Healthcare?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sensus Healthcare
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sensus Healthcare?

Wall Street analysts have given Sensus Healthcare a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sensus Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Sensus Healthcare's next earnings date?

Sensus Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Sensus Healthcare
.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) announced its quarterly earnings results on Thursday, November, 5th. The company reported ($0.10) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.13) by $0.03. The business earned $1.62 million during the quarter, compared to analyst estimates of $2.24 million. Sensus Healthcare had a negative return on equity of 23.08% and a negative net margin of 34.01%.
View Sensus Healthcare's earnings history
.

What price target have analysts set for SRTS?

5 analysts have issued 12-month target prices for Sensus Healthcare's stock. Their forecasts range from $3.00 to $6.00. On average, they expect Sensus Healthcare's stock price to reach $4.38 in the next twelve months. This suggests a possible upside of 35.6% from the stock's current price.
View analysts' price targets for Sensus Healthcare
.

Are investors shorting Sensus Healthcare?

Sensus Healthcare saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 195,000 shares, an increase of 31.4% from the September 30th total of 148,400 shares. Based on an average trading volume of 23,600 shares, the days-to-cover ratio is currently 8.3 days. Approximately 1.7% of the company's stock are short sold.
View Sensus Healthcare's Short Interest
.

Who are some of Sensus Healthcare's key competitors?

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

Who are Sensus Healthcare's key executives?

Sensus Healthcare's management team includes the following people:
  • Mr. Joseph C. Sardano, Co-Founder, Chairman, CEO & Pres (Age 67, Pay $466.8k)
  • Mr. Stephen Cohen, Co-Founder & Exec. VP (Age 60, Pay $521.26k)
  • Mr. Javier Rampolla, Chief Financial Officer (Age 48)
  • Mr. Nicolas Soro, Chief Operating Officer (Age 35)
  • Mr. James Russell Price, Chief Technology Officer (Age 59)
  • Mr. Michael J. Sardano, VP, Gen. Counsel & Corp. Sec. (Age 32)
  • Dr. Mark S. Nestor, Medical Director & Member of Medical Advisory Board
  • Dr. Clay Jefferies Cockerell, Clinical Director & Member of Medical Advisory Board (Age 63)

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

Who are Sensus Healthcare's major shareholders?

Sensus Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (0.31%) and Sheaff Brock Investment Advisors LLC (0.13%). Company insiders that own Sensus Healthcare stock include Kalman Fishman, Richard Golin and Stephen Brad Cohen.
View institutional ownership trends for Sensus Healthcare
.

Which institutional investors are buying Sensus Healthcare stock?

SRTS stock was acquired by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., and Sheaff Brock Investment Advisors LLC.
View insider buying and selling activity for Sensus Healthcare
.

How do I buy shares of Sensus Healthcare?

Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $3.23.

How big of a company is Sensus Healthcare?

Sensus Healthcare has a market capitalization of $53.30 million and generates $27.26 million in revenue each year. The company earns $-1,700,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. Sensus Healthcare employs 53 workers across the globe.

What is Sensus Healthcare's official website?

The official website for Sensus Healthcare is www.sensushealthcare.com.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.